samedan logo

 
 
spacer
home > pmps > spring 2019 > the case for blockchain technology
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

 
News and Press Releases

Clinical trial platform provider encapsia welcomes new COO

Horsham, United Kingdom, 5th January 2023: Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years of expertise to the role, specialising in the management of data-related projects in clinical trials and statistical analysis software. His adoption of a future-facing approach to clinical research supports encapsia’s vision of transforming clinical trials for the benefit of the biotech, pharma and biopharma industries.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement